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Abstract
Mutations in PTEN-induced putative kinase 1 (PINK1) are a cause of early onset Parkinson’s disease (PD). Loss of PINK1 func-
tion causes dysregulation of mitochondrial calcium homeostasis, resulting in mitochondrial dysfunction and neuronal cell death.
We report that both genetic and pharmacological inactivation of the mitochondrial calcium uniporter (MCU), located in the inner
mitochondrial membrane, prevents dopaminergic neuronal cell loss in pink1Y431* mutant zebrafish (Danio rerio) via rescue of mito-
chondrial respiratory chain function. In contrast, genetic inactivation of the voltage dependent anion channel 1 (VDAC1), located
in the outer mitochondrial membrane, did not rescue dopaminergic neurons in PINK1 deficient D. rerio. Subsequent gene expres-
sion studies revealed specific upregulation of the mcu regulator micu1 in pink1Y431* mutant zebrafish larvae and inactivation of
micu1 also results in rescue of dopaminergic neurons. The functional consequences of PINK1 deficiency and modified MCU activ-
ity were confirmed using a dynamic in silico model of Ca2+ triggered mitochondrial activity. Our data suggest modulation of MCU-
mediated mitochondrial calcium homeostasis as a possible neuroprotective strategy in PINK1 mutant PD.
Introduction
Parkinson’s disease (PD) is a common neurodegenerative disorder,
resulting in both motor and non-motor symptoms (Kalia & Lang,
2015). The pathological hallmark of PD is loss of dopaminergic
neurons in the substantia nigra pars compacta. Mitochondrial dys-
function was ﬁrst described in post mortem tissue of patients with
sporadic PD. More recently, it has been closely linked to Mendelian
forms of familial PD, in particular to early onset PD due to parkin,
PTEN-induced putative kinase 1 (PINK1) and DJ-1 mutations
(Exner et al., 2012). Loss of PINK1 function results in mitochon-
drial calcium overload, thought to be due to impaired calcium efﬂux
from the mitochondria (Gandhi et al., 2009; Marongiu et al., 2009).
The reduced mitochondrial calcium capacity in PINK1 deﬁcient neu-
rons results in increased oxidative stress which in turn leads to
reduced glucose uptake and a lowering of the threshold for the
opening of the permeability transition pore (PTP). This suggests that
impaired mitochondrial calcium homeostasis is at least one of the
pathological mechanisms resulting from PINK1 deﬁciency.
Mitochondria are key modulators of intracellular calcium home-
ostasis. The voltage-dependent anion channel 1 (VDAC1) is located
within the outer mitochondrial membrane and transports calcium
into the intermembrane space (Shoshan-Barmatz & Golan, 2012).
Calcium then enters the mitochondrial matrix through a dedicated
channel within the inner mitochondrial membrane referred to as the
mitochondrial calcium uniporter (MCU) (Baughman et al., 2011; De
Stefani et al., 2011). Silencing MCU severely reduces mitochondrial
calcium uptake but mitochondrial respiration and membrane poten-
tial remain fully intact. The MCU channel is part of a multisubunit
modular complex that includes regulators of its activity, calcium
sensitivity and expression (Murgia & Rizzuto, 2015). Additional
components of this four MCU complex include mitochondrial cal-
cium uptake 1 and 2 (MICU1, MICU2), the essential MCU regula-
tor (EMRE) and the mitochondrial calcium uniporter regulator 1
(MCUR1) (see Murgia & Rizzuto, 2015 for review). Recently, a
physical and functional interaction of MCU with VDAC1 has also
been reported (Liao et al., 2015).
Zebraﬁsh are increasingly used to study mechanisms linked to
human neurodegenerative diseases. They are vertebrates and there-
fore more closely related to humans than Caenorhabditis elegans or
Drosophila. Their genome is fully characterized and contains
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orthologues for approximately 70% of all human genes, but 82% for
all human disease genes (Howe et al., 2013). We recently reported
our ﬁndings in a zebraﬁsh mutant line carrying a Stop mutation
(pink1Y431*, from here on referred to as pink1/ for homozygous
pink1 mutant larvae) in the kinase domain of pink1, the zebraﬁsh
orthologue of the human PD gene PINK1 (Flinn et al., 2013).
pink1/ already resulted in impaired function of the mitochondrial
respiratory chain and loss of dopaminergic neurons at 3 days post
fertilization (dpf). Zebraﬁsh embryos are eminently amenable to
both genetic and pharmacological manipulation.
Here, we demonstrate a rescue effect of both pharmacological and
genetic MCU inhibition on the dopaminergic neurons via normalisa-
tion of mitochondrial function. We further report speciﬁc transcrip-
tional upregulation of micu1 in pink1/ zebraﬁsh larvae. Genetic
inactivation of micu1 also results in rescue of the dopaminergic neu-
rons. In contrast, genetic inactivation of vdac1 did not protect the
dopaminergic neurons in pink1/ zebraﬁsh larvae.
To understand these ﬁndings on a more mechanistic level, we
applied our previously developed mathematical model to investigate
the role of modiﬁed Ca2+ dynamics on the respiratory function
(Komin et al., 2015). Incorporating the reported effects of PINK1
on Ca2+ homeostasis (Gandhi et al., 2009; Gautier et al., 2012) into
the model reveals a dramatic decrease in respiratory capacity that
can be compensated by modiﬁed MCU activity. This independent
conﬁrmation of the experimental results strongly supports the essen-
tial role of mitochondrial energy metabolism to dopaminergic neu-
ronal survival. Our data suggest that modulation of MICU1 and
MCU may be a promising target for future neuroprotective strategies
in PINK1-related PD.
Materials and methods
Animal maintenance
Adult wt (AB and TL wt lines) and pink1/ (Flinn et al., 2013)
zebraﬁsh were maintained according to methods previously
described (Matthews et al., 2002). Adult zebraﬁsh and larvae were
kept in E3 medium at 28.5 °C.
RT-PCR
RNA was isolated from a pool of 20 embryos using Tri reagent
(Sigma Aldrich) and cDNA was generated using Verso cDNA
synthesis kit (Thermo Scientiﬁc). RT-primers (50-AGACTGTCAG
GAGAGCACAC-30, 50-GACGTACAGAAATCACCGGC-30) were
designed against mcu (ENSDART00000130884) and RT-PCR was
performed to determine mcu expression at different developmental
stages (1, 24, 48 and 72 hpf). Primers (50-GGCAAATCTGCCAGA
GACAT-30, 50-TGTCCGTGTTCCACTTCTCA-30) were also
designed against the transcript vdac1 (ENSDART00000066373) and
RT-PCR was performed to determine vdac1 expression during early
developmental stages (1, 24, 48 and 72 hpf). Each PCR reaction
mixture consisted of 10 lL Biomix Red TM (Bioline), 2 lL for-
ward primer, 2 lL reverse primer, 4 lL H2O and 2 lL of cDNA.
The reaction was heated to 95 °C for 3 min with 34 cycles (95 °C
for 30 s, 60 °C for 30 s, and 72 °C for 1 min). This was followed
by a ﬁnal incubation at 72 °C for 5 min.
Morpholino injections
Morpholino (Gene Tools) were employed to functionally knock-
down mcu, vdac1 and micu1. Single cell stage embryos were
selected to microinject 1 nL of morpholinos directed against mcu
(0.9 mM of mcu e2i2 morpholino (MO) – 50-CATCAAGAGTAA
AGCACTAACCTGG-30), vdac1 (0.9 mM of vdac1 e5i5 MO –
50-TGCATAAATTCGTACCCAGTGTTTG-30 combined with vdac1
i6e7 MO – 50-CCGTCATTCCTGATATTAAACACA-30) and micu1
(0.5 mM of micu1 e10i10 MO – 50-GACTCTTATCAAGCTGCCC
ACCTGA-30). The efﬁcacy of the morpholino-mediated knockdown
was assayed by RT-PCR using primers against ﬂanking exons of
the MO target site. The primer sequences are as follows: mcu- F
50-AGAGATGGCTGCGAAAGTGT-30: R 50-AAAACACCCACCG
TGTCACT-30; vdac1- F 50-GCTGAACACGGCCTGACCTT-30: R
50-CCT CCGGCGTTAATGTTCTT-30: micu1- F 50-GGCTGATCT
GAAGGGCAAAC-30: R 50-GTCCGACAGCTCCACTTTTG-30.
Quantitative-PCR
Twenty embryos were used per genotype for RNA isolation. Quanti-
tative PCR (Q-PCR) analysis was conducted with gene-speciﬁc pri-
mers (mcu- 50-AGACTGTCAGGAGAGCACAC-30, 50-GACGTAC
AGAAATCACCGGC-30; emre- 50-TGTGTTCTCCTCAGCTCGG-30,
50-CTGATCAGAGTGCCGACGTA-30; mcur1- 50-CTCATGCAA
TGGTCCAGCTG-30, 50-CTGCTGTGTCTTGGTAGCCA-30; micu2-
50-TGAAGAGGACAACGAGGCAT-30, 50-ACAGAGATGGCGAA
GTCCTC-30; micu1- 50-GGCGGGCTCTTCAGTTAAAC-30, 50-CAT
ACTCCATCACCTTGCGG-30), which were optimized for annealing
temperature, concentration and efﬁciency. SYBR green master mix
(Agilent) was utilized for the enzyme reaction, reaction incubated
and analyzed by Stratagene MxPro 3000p Real Time PCR machine
(Stratagene). The fold change in expression was quantiﬁed by nor-
malizing the threshold cycle (CT) values of the target mRNAs to
the CT values of the internal control ef1alpha (ENSDARG
00000020850) in the same samples (ΔCT = CTTarget  CTEF1alpha).
It was further normalized with the wt control
(ΔΔCT = ΔCT  CTControl). The fold change in expression was
then obtained by 2ΔΔCT. The results are representative of three bio-
logical replicates, each consisting of three technical replicates.
Chemical treatment
The pharmacological inhibitor of MCU, Ruthenium red (RR) was
used to conﬁrm the results from the functional knockdown of mcu
using MO. RR (Sigma Aldrich) was dissolved in sterile water at
10 lM concentration and treated to larvae in E3 medium for 3 days
(n = 10 of embryos per genotype and experiment).
Whole mount in situ hybridization
Whole mount in situ hybridization (WISH) was performed as previ-
ously described (Jowett & Lettice, 1994; Thisse & Thisse, 2008;
Shimizu et al., 2015). Speciﬁc primers with artiﬁcially introduced
T7 and SP6 polymerase sequence were used to perform PCR ampli-
ﬁcation of desired gene of interest. The primer sequences are as fol-
lows: th- F 50-AATTAACCCTCACTAAAGGGAGAATGCCGA
ATTCAAGCAGCTCCAC-30: R 50-TAATACGACTCACTATAGG
GAGAAGCGTGCCGTATGTACTGTGTGC-30; mcu- F 50-TAAT
ACGACTCACTATAGGGGCTGAGTAAGAAAGCCGAGC-30: R
50-GATTTAGGTACTATAGGCACCACATCCCGAAATCTC-30;
micu1- F 50-TAATACGACTCACTATAGGGAGACATCAATGAA
CACAGGGACG-30: R 50-ATTTAGGTGACACTATAGAAGATC
ACACAACATGGTCCGACA-30; vdac1- F 50-TAATACGACTCA
CTATAGGGTCGACTCCTCCTTTTCTCCA-30: R 50-GATTTAGG
TGACACTAATAGACGGACGCAGCAGGTAGTAT-30. The PCR
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product was used as a template for synthesis of the digoxigenin-
labeled antisense RNA probe using in vitro transcription. Speciﬁ-
cally, an RNA probe against tyrosine hydroxylase (TH) was synthe-
sized to label dopaminergic neurons. An anti-DIG antibody coupled
to alkaline phosphatase was used to detect the hybridized RNA
probe. Zebraﬁsh larvae were embedded in 3% methylcellulose and
photographed. The mean number of these diencephalic dopaminergic
neurons in experimental larvae were calculated over three indepen-
dent experiments (n = 10 of embryos per genotype and experiment).
Mitochondrial complex I–IV assays
Assays were performed as previously described (Flinn et al., 2013).
Brieﬂy, 5 dpf zebraﬁsh larvae were harvested into Eppendorf tubes
of 20 larvae per experimental condition, and the mitochondrial frac-
tion was isolated. Homogenates were freeze thawed three times in
liquid N2 before being used for spectrophotometric assessment of
respiratory chain complexes. The speciﬁc activity of complex I–IV
was normalized to that of citrate synthase. Complex I activity is
determined by following the oxidation of NADH to NAD+ and the
simultaneous reduction of a dye which leads to increased absorbance
at OD = 450 nm. All mitochondrial complex activity assays were
performed in triplicate.
Data analysis
In all experiments, error bars indicate the standard error of mean
(SEM, at least three independent experiments). All experiments were
carried out in biological triplicate unless speciﬁcally stated other-
wise. The following statistical tests were applied to determine statis-
tical signiﬁcance: Q-PCR: unpaired two-tailed, two sample T test;
TH in situ hybridisation experiments (counting of dopaminergic neu-
rons) and complex I activity assay experiments: One way ANOVA fol-
lowed by Tukey’s multiple comparison test.
In silico modeling
To integrate the experimental data mechanistically, we adapted our
previous developed model (Komin et al., 2015). The rate equa-
tion model takes into account the cytosolic Ca2+ dynamics that is
mainly driven by Ca2+ release from the endoplasmic reticulum (ER)
through inositol trisphosphate receptors (IP3Rs) into the cytosol and
removal of cytosolic Ca2+ back into the ER by sacro-ER Ca2+
ATPases (SERCAs) and into the extracellular space by plasma
membrane Ca2+ ATPases (PMCAs) (Fig. 4A). Within the cytosol
Ca2+ is taken up by mitochondria via the MCU where it triggers
ATP production by TCA cycle activity and released into the cytosol
by the sodium Ca2+ exchanger (NCX). The adapted model considers
the corresponding Ca2+ ﬂuxes and the triggered mitochondrial activ-
ity is simulated by a ﬁrst principle-based module (Bertram et al.,
2006). The resulting cytosolic ATP concentration subsequently
determines SERCA and PMCA mediated ﬂuxes and therefore
cytosolic Ca2+ dynamics. The mathematical equations were imple-
mented in a customized Ca2+ program.
Results
MCU inactivation rescues dopaminergic neurons in PINK1
deficiency
mcu (ENSDARG00000101175), the zebraﬁsh orthologue of human
MCU (ENSG00000156026), was identiﬁed using Ensembl genome
browser. mcu shares 70.7% DNA and 78.8% protein identity with
human MCU. mcu was already expressed at 1 h post fertilization
(hpf), expression was then constant throughout development
(Fig. 1A). WISH of mcu indicated predominant expression in brain
tissue (Fig. 1B). Q-PCR analysis revealed similar mcu mRNA tran-
script levels in pink1/ and wild type (wt) larvae at 3 dpf
(Fig. 1C). We next applied the morpholino (MO) antisense strategy
to genetically inactivate mcu. Injection of a splice site MO targeted
at the exon 2/intron 2 junction of mcu at single cell stage resulted in
a dose-dependent skipping of exon 2 (Fig. 1D) with marked reduc-
tion in mRNA transcript levels (Fig. 1E). This MO-induced knock-
down (k/d) of mcu did not alter the overt development, spontaneous
motor behavior or phenotypic characteristics until 5 dpf (data not
shown). As previously observed, the number of diencephalic
dopaminergic neurons within the 1, 2, 4 and 5 subgroups according
to the Rink-Wullimann classiﬁcation were reduced in pink1/ at
3 dpf (P = 0.0128) (Rink & Wullimann, 2001; Flinn et al., 2013).
At 3 dpf, mcu k/d did not change the number of dopaminergic neu-
rons in wt larvae, but resulted in a marked rescue of dopaminergic
neurons in pink1/ (P = 0.0085) (Fig. 2A,B). We next sought to
validate the observed protective effect of genetic MCU inactivation
using a different, pharmacological approach. RR has long been rec-
ognized as a pharmacological inhibitor of mitochondrial calcium
inﬂux prior to the discovery of the MCU as such (Moore, 1971).
Treatment of wt larvae with RR at a concentration of 10 lM for
3 days did not have an effect on the number of diencephalic
dopaminergic neurons, but – as predicted – had a marked protective
effect on the seven dopaminergic neurons in pink1/ larvae
(P < 0.0001, Fig. 2C), similar to the rescue effect observed after
genetic MCU inactivation. We next sought to identify the mecha-
nism underlying the observed rescue effect of MCU inactivation in
PINK1 deﬁciency. As mentioned earlier, we had previously
observed a marked decrease in the activity of complex I in pink1/
(Flinn et al., 2013). We hypothesized that MCU inactivation rescues
dopaminergic neurons via normalization of mitochondrial respiratory
chain function. As predicted, MO-mediated genetic inactivation of
MCU as described above had a rescue effect on complex I activity
in pink1/ larvae at 5 dpf (P = 0.007, Fig. 2D).
The effect of VDAC1 and MCU inactivation are distinct
We next investigated whether the observed rescue effect of either
genetic or pharmacological MCU inhibition on dopaminergic neu-
rons in PINK1 deﬁciency is speciﬁc or could also be observed after
inhibition of the outer mitochondrial membrane channel VDAC1.
vdac1 (ENSDARG00000045132) the zebraﬁsh orthologue of human
VDAC1 (ENSG00000213585) shares 77.1% DNA sequence identity
with VDAC1 and 85.5% protein identity. vdac1 is already expressed
at 1 hpf with similar expression levels at 1, 2 and 3 dpf (Fig. 3A).
Marked MO-mediated knockdown of vdac1 was achieved using a
combination of two splice site MOs directed against the exon 5/in-
tron 5 splice site and the intron 6/exon 7 (Fig. 3B). In contrast to
MCU inactivation, MO-mediated k/d of vdac1 did not rescue dien-
cephalic dopaminergic neurons in pink1/ larvae (P > 0.99,
Fig. 3C).
Altered functional regulation of MCU in PINK1 deficiency
As described above, mcu expression levels in pink1/ larvae were
similar to the expression levels observed in wt larvae but the marked
rescue effect of mcu silencing suggested a possible dysregulation in
MCU function. We hypothesized that this dysregulation may be due
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to altered expression levels of the MCU regulators micu1
(ENSDARG00000063358), micu2 (ENSDARG00000009939), emre
(ENSDARG00000095826) or mcur (ENSDARG00000016964) in
pink1/. We observed a 4 fold upregulation (4.01, SD  1.36,
Fig. 3D) of micu1 (P = 0.0066) in pink1/ compared to wt larvae
at 3 dpf. mRNA expression levels of micu2, emre and mcur also
varied between pink1/ and wt larvae but the observed differences
did not reach statistical signiﬁcance (Fig. 3E–G). micu1
(ENSDARG00000063358) the zebraﬁsh orthologue of human
MICU1 (ENSG00000107745) shares 91.38% DNA identity and
74.3% protein identity with MICU1. We next applied the MO k/d
strategy to further investigate the possible functional relevance of
the observed micu1 transcriptional upregulation which suggested a
possible change in the calcium trafﬁcking properties of MCU. Splice
Fig. 1. mcu expression. (A) RT-PCR analysis showing consistent expression of mcu throughout development (1, 24, 48 and 72 hpf). (B) In situ hybridization
with dorsal (left) and lateral (right) views of mcu expression in 3 dpf zebraﬁsh larvae, demonstrating strong expression in the brain. (C) Quantiﬁcation of mcu
mRNA at 3 dpf, demonstrating similar expression levels in wt and pink1/. (D) RT-PCR analysis of mcu knockdown using antisense morpholino (MO) at 3
dpf, demonstrating the marked effect of MO mediated mcu k/d on mcu wild type transcript levels. (E) Q-PCR based conﬁrmation of marked effect of MO-
mediated mcu k/d on mcu mRNA transcript levels (****P < 0.0001). [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
Fig. 2. Knockdown of mcu leads to rescue of dopaminergic neurons. (A) Dopaminergic (DA) neuronal cell count in wt, wt MCU (wt microinjected with MO
against mcu), pink1/, pink1/ MCU (pink1/ microinjected with MO against mcu) zebraﬁsh larvae at 3 dpf. DA neuronal cell count is reduced in pink1/
(*P = 0.012) but completely rescued after MCU inactivation (**P = 0.0085). The scale on the y axis reﬂects % of DA neurons compared to wt controls. (B)
Representative image showing dopaminergic neurons in the diencephalon [using tyrosine hydroxylase (TH) whole mount in situ (WISH) staining] in wt controls
and pink1/ zebraﬁsh injected with and without mcu MO. (C) Dopaminergic (DA) neuronal cell count in wt, wt embryos treated with Ruthenium red (RR) (wt
RR), pink1/ and pink1/ embryos treated with RR (pink1/ RR) with complete rescue of DA neurons in pink1/ larvae after RR treatment
(****P < 0.0001). The scale on the y axis reﬂects % of DA neurons compared to wt controls. (D) WT vs pink1/ (***P = 0.0007). Mitochondrial complex I activity
is restored in 5 dpf pink1/ following mcu k/d (**P = 0.0071). Complex I activity is measured in lmol oxidized NADH per 1 unit of citrate synthase activity and
set to 100% for the complex I activity in WT controls. The scale on the y axis reﬂects % of complex I activity compared to wt controls. [Colour ﬁgure can be viewed at
wileyonlinelibrary. com].
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site MO directed against the exon 10/intron 10 boundary established
k/d of micu1 (Fig. 3H). MICU1 deﬁcient zebraﬁsh larvae did not
develop any overt developmental, behavioural or phenotypical
abnormalities (data not shown). MO-mediated knockdown of micu1
resulted in protection of the diencephalic dopaminergic neurons sim-
ilar to the effect observed after mcu k/d (P = 0.0004; Fig. 3I).
Taken together, our data suggest MICU1 mediated activation of
MCU in PINK1 deﬁciency.
In silico modeling
To investigate the potential role of energy metabolism as a mecha-
nism for the observed changes in dopaminergic neuronal viability
based on the selective vulnerability hypothesis (Chan et al., 2009),
we simulated the different scenarios with our recently developed
and validated in silico model (Komin et al., 2015). The rate equa-
tion model considers the cytosolic dynamics and its impact on mito-
chondrial activity based on ﬂuxes between the two compartments
mediated by well-established molecular interactions summarized in
in Fig. 4A. Based on our previously determined parameter set
describing wt dynamics (Fig. 4B), the mechanistic approach allows
for testing the effect of PINK1 loss of function (Gandhi et al.,
2009) and the impact of MCU activity (Fig. 4A). To simulate the
impaired PINK1 case, we increased the ﬂux through the MCU by
10% and decreased the ﬂux rate of the Na/Ca2+ exchanger by 10%
as well as the glucose uptake rate by 30%. These values were esti-
mated by scanning the model parameters in the physiological range
in order to reproduce the experimental results. While the resulting
cytosolic Ca2+ dynamics (Cac) is hardly modiﬁed compared to wt
condition (upper panel Fig. 4B), the mitochondrial Ca2+ concentra-
tion (Cam) and oxygen ﬂux (J0) exhibit a signiﬁcant difference (mid-
dle panel Fig. 4B). In particular, the amplitude of J0 that describes
the oxygen consumption rate and is therefore a measure of
respiration activity, decreases dramatically due to mitochondrial
Ca2+ overload. This effect can be compensated in the model by
decreasing MCU activity by 14% preventing mitochondrial Ca2+
overload and restoring respiratory (lower panel Fig. 4B). The differ-
ent scenarios are summarized in Fig. 4C with respect to the oxygen
consumption rate corresponding to respiratory activity. The
described ﬂux modiﬁcations lead to a very similar picture as in the
experimentally determined neuronal survival. Since neuronal sur-
vival will not depend linearly on respiration activity, we performed
comprehensive model parameter scans to test the stability of our
results. Fig. 4D exhibits a parameter scan with respect to MCU
activity (Puni) relative to wt conditions (Puni = 1) and fructose-
bisphosphate (FBP) that 10 depends on the glucose uptake rate. The
obtained dependency of respiration on Puni and FBP as well as simi-
lar results from additional parameter scans demonstrate that the
mechanistic modeling support of the experimental ﬁndings do not
depend on speciﬁc parameter combinations but are robust for a wide
physiological parameter range.
Discussion
Calcium has repeatedly been implicated in the pathogenesis of PD.
We now provide further evidence for a complex interplay between
altered mitochondrial function, impaired mitochondrial calcium
homeostasis and the MCU complex in PINK1 deﬁciency. Our obser-
vation of normal development in MCU-deﬁcient zebraﬁsh larvae is
in keeping with the normal development of MCU/ mice on the
outbred, mixed CD1 genetic background (Murphy et al., 2014). Dif-
ferences in the genetic background may explain the discrepancy
between the lack of an effect of MCU inactivation on zebraﬁsh
development in our experiments compared to the marked effect
observed by others (Prudent et al., 2013). There are ongoing con-
cerns about potentially misleading conclusions resulting from MO-
Fig. 3. VDAC1 and MICU1 analysis. (A) RT-PCR analysis demonstrating expression of vdac1 at 1, 24, 48 and 72 hpf. (B) RT-PCR analysis of vdac1 in wt
controls and after MO mediated vdac1 k/d, demonstrating a marked effect of the vdac1 MO on vdac1 wt transcript levels. (C) Dopaminergic (DA) neuronal cell
count in wt, wt vdac1 (wt injected with MO against vdac1), pink1/, pink1/ vdac1 (pink1/ injected with MO against vdac1) at 3 dpf, reﬂecting the lack
of an effect of VDAC1 inactivation on DA neuronal cell count in pink1/ (P > 0.99) (*P = 0.0105). (D) qPCR analysis of micu1, showing signiﬁcant upregu-
lation of micu1 in pink1/ larvae at 3 dpf compared to wt (**P = 0.0066). (E) qPCR analysis of micu2, showing a non-signiﬁcant down regulation of micu2
in pink1/ larvae at 3 dpf compared to wt (nsP = 0.0902). (F) qPCR analysis of mcur, showing a non-signiﬁcant upregulation of mcur in pink1/ larvae at 3
dpf compared to wt (nsP = 0.2088). (G) qPCR analysis of emre, showing a non-signiﬁcant down regulation of emre in pink1/ larvae at 3 dpf compared to wt
(nsP = 0.2712). (H) RT-PCR analysis of micu1 at 3 dpf in uninjected larvae (WT) and after MO mediated k/d (micu MO), demonstrating the marked effect of
micu1 MO injection on micu1 mRNA transcript levels. (I) Dopaminergic (DA) neuronal cell count in wt, wt micu1 (wt injected with MO against micu1),
pink1/, and pink1/ micu1 (pink1/ injected with MO against micu1) zebraﬁsh larvae at 3 dpf, demonstrating the rescue effect of MICU1 inactivation on
DA neurons in PINK1 deﬁciency (***P = 0.0004).
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based experiments. However, erroneous effects of MO are typically
due to nonspeciﬁc toxic effects (Kok et al., 2015; Stainier et al.,
2015). None of the typical morphological characteristics of these
often p53-mediated, non-speciﬁc off-target effects were observed
after MO-mediated k/d of mcu. Furthermore, we were able to vali-
date our MO-based data using a completely different strategy,
namely pharmacological inhibition of MCU with RR. We therefore
consider it to be unlikely that the observed rescue effect of mcu k/d
could be due to a non-speciﬁc off-target effect of the MOs used in
our experiments. Further validation of the presented data could be
undertaken in double-knockout zebraﬁsh lines which are both pink1
and mcu mutant to further reduce the already unlikely possibility of
the observed rescue effect being due to a non-speciﬁc off-target
effect. MCU k/d had previously been shown to reduce excitotoxic-
ity-induced neuronal cell death after NMDA receptor activation
in vitro (Qiu et al., 2013). However, excitotoxic stress is not
considered to be a key player in PD pathogenesis and modulation of
excitotoxic stress is unlikely to be the underlying mechanism in our
zebraﬁsh model of PINK1 deﬁciency.
MICU1 is thought to have a major role in regulating MCU chan-
nel activity during high cytosolic calcium concentrations (Ahuja &
Muallem, 2014). The speciﬁc increase in micu1 expression as well
as the protective effect of micu1 k/d on dopaminergic neurons sug-
gests that MICU1 activation is involved in the mechanisms leading
to dopaminergic neuronal cell loss via mitochondrial calcium over-
load in PINK1 deﬁciency. Further studies in other in vitro and
in vivo model systems of PINK1 deﬁciency as well as, ideally,
assessment in PINK1 mutant patient tissue is necessary to determine
whether the observed transcriptional upregulation of micu1 is speci-
ﬁc for pink1/ zebraﬁsh or more generally observed in PINK1
deﬁciency. However, any attempts to further study the observed res-
cue effect of both MCU and MICU1 inactivation in higher
Fig. 4. Mathematical modeling of Ca2+ triggered mitochondrial energy. (A) Scheme of the rate equation model and the considered effect of PINK1 deletion.
The model combines cytosolic Ca2+ dynamics driven by IP3R mediated release from the endoplasmic reticulum (ER) and removal by sarco/endoplasmic reticu-
lum Ca2+-ATPase (SERCA) and plasma membrane Ca2+ ATPase (PMCA) pumps with the induced mitochondrial ATP production. The effect of PINK1 deﬁ-
ciency on glucose uptake and mitochondrial Ca2+ handling is indicated in purple. NCX = sodium Ca2+ exchanger. (B) Dynamic modeling results of
mitochondrial Ca2+ concentrations and resulting oxygen ﬂux (Jo) for wt, pink1/ and pink1/ + MCU down regulation conditions. Compared to the wt sce-
nario (top panel), pink1/ leads to mitochondrial Ca2+ overload and subsequently to smaller Jo amplitudes indicating decreased respiration (middle panel). This
effect could be compensated by down regulation of MCU reestablishing mitochondrial Ca2+ homeostasis and mitochondrial activity (bottom panel). (C) Respira-
tion activity for the different conditions. The oxygen consumption rate as an indicator for respiratory activity exhibit a similar pattern to the dopaminergic neu-
ronal survival and complex I activity (see Fig 2). (D) Intensive parameter scans have shown the stability of the compensatory effect of MCU down regulation
compared to wt conditions (Puni = 1) on respiration measured by oxygen consumption. The model also suggests a potential intervention by up regulation of glu-
cose uptake leading to higher fructose biphosphate (FBP) concentrations. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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vertebrates will be challenging due to the absence of dopaminergic
neuronal cell loss in Pink1 k/o mice (Oliveras-Salva et al., 2011).
Of note, lack of MCU does not protect heart cells against ischemic
cell death despite an abolished effect of ischemia on the activation
of the mitochondrial permeability transition pore in Mcu/ mice
(Pan et al., 2013). Further work is required to conﬁrm that the
observed beneﬁcial effect of mcu k/d in our pink1/ larvae is
indeed due to a modulatory effect on mitochondrial calcium home-
ostasis with resulting normalization of mitochondrial respiratory
chain function rather than exerting its effect via modulation of other
mechanisms linked to the pathogenesis of PD such as an effect on
mitophagy (Sousa et al., 2003; Deas et al., 2011).
All three VDAC isoforms are equivalent in allowing mitochon-
drial calcium loading upon agonist stimulation, but only VDAC1
silencing selectively impairs the transfer of the low-amplitude apop-
totic calcium signals (De Stefani et al., 2011). VDAC1 has been
reported to physically interact with MCU (Liao et al., 2015).
VDAC1 has been implicated in neuronal cell death in both Alzhei-
mer’s disease (AD) and PD (Reddy, 2013; Alberio et al., 2014). In
addition to its role in Calcium homeostasis, VDAC1 has also been
implicated in PINK1/Parkin-mediated mitophagy (Geisler et al.,
2010). We were therefore intrigued to observe a complete lack of a
neuroprotective effect of VDAC1 inactivation in pink1/ zebraﬁsh.
This further suggests a speciﬁc and prominent role of MCU in
PINK1 deﬁciency-linked neuronal cell death.
Due to the role of Ca2+ in activation of mitochondrial respiration
(Chan et al., 2009), our ﬁndings point to energy metabolism as a
contributing effector of neuron survival what is further supported by
our mechanistic in silico studies. This perspective is in accordance
with the selective vulnerability hypothesis that assumes the larger
energetic load of dopaminergic neurons to be a major reason for
their increased cell death rate in PD (Pissadaki & Bolam, 2013).
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